These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8448706)

  • 1. Technology assessment and cost-effectiveness analysis: misguided guidelines?
    Naylor CD; Williams JI; Basinski A; Goel V
    CMAJ; 1993 Mar; 148(6):921-4. PubMed ID: 8448706
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.
    Gafni A; Birch S
    CMAJ; 1993 Mar; 148(6):913-7. PubMed ID: 8448705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tentative guidelines for using clinical and economic evaluations revisited.
    Laupacis A; Feeny D; Detsky AS; Tugwell PX
    CMAJ; 1993 Mar; 148(6):927-9. PubMed ID: 8448707
    [No Abstract]   [Full Text] [Related]  

  • 4. On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales.
    Birch S; Gafni A
    Health Econ; 2002 Apr; 11(3):185-91. PubMed ID: 11921316
    [No Abstract]   [Full Text] [Related]  

  • 5. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
    Laupacis A; Feeny D; Detsky AS; Tugwell PX
    CMAJ; 1992 Feb; 146(4):473-81. PubMed ID: 1306034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of subjective values to medical technology assessment and health policy.
    Diamond GA
    J Invasive Cardiol; 1993; 5(1):17-22. PubMed ID: 10148297
    [No Abstract]   [Full Text] [Related]  

  • 7. Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis.
    Eddy D
    Health Aff (Millwood); 2007; 26(4):w500-15. PubMed ID: 17580317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical necessity: trying to reach consensus.
    Phillips L
    Hosp Technol Ser; 1996 May; 15(6):5, 10. PubMed ID: 10158519
    [No Abstract]   [Full Text] [Related]  

  • 9. The limited regulatory potential of medical technology assessment.
    Elhauge E
    Va Law Rev; 1996 Nov; 82(8):1525-1622. PubMed ID: 16715565
    [No Abstract]   [Full Text] [Related]  

  • 10. Does assessment of medical practices have a future?
    Capron AM
    Va Law Rev; 1996 Nov; 82(8):1623-40. PubMed ID: 16715566
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficult decisions: weighing treatment costs and benefits.
    Wainio JA
    Hosp Technol Ser; 1995 Jan; 14(1):1-3. PubMed ID: 10140805
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost and effectiveness: approval and payment for Pulverizer.
    Riegelman R
    Md Med; 2002; 3(3):50-4. PubMed ID: 12214498
    [No Abstract]   [Full Text] [Related]  

  • 14. Basic concepts and fundamental issues in technology assessment.
    Franklin C
    Intensive Care Med; 1993; 19(2):117-21. PubMed ID: 8486866
    [No Abstract]   [Full Text] [Related]  

  • 15. Resource allocation of adult intensive care.
    Noseworthy TW
    Ann R Coll Physicians Surg Can; 1988 May; 21(3):199-202. PubMed ID: 11650081
    [No Abstract]   [Full Text] [Related]  

  • 16. Some alternative perspectives concerning medical technology assessment.
    Diamond GA
    J Invasive Cardiol; 1992; 4(1):39-44. PubMed ID: 10149903
    [No Abstract]   [Full Text] [Related]  

  • 17. Technology assessment in the German context.
    Drummond M
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S3. PubMed ID: 17619919
    [No Abstract]   [Full Text] [Related]  

  • 18. Implantable cardioverter/defibrillator therapy: the meaning of terms.
    Smith ER
    Can J Cardiol; 2000 Oct; 16(10):1325-6. PubMed ID: 11064309
    [No Abstract]   [Full Text] [Related]  

  • 19. Health care technology: how can we tell if we can afford it? A Canadian viewpoint.
    Dolan A; Zingg W
    J Long Term Eff Med Implants; 1993; 3(4):277-82. PubMed ID: 10146729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology in medicine -- ethics, politics and reality.
    Watts JL; Blanchard R; Guyatt G; Miller D; Singer P; Haynes RB; Van Loon R
    Ann R Coll Physicians Surg Can; 1992 Feb; 25(1):51-4. PubMed ID: 11653977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.